Protecting the underscreened women in developed countries: the value of HPV test

dc.contributor.authorIbáñez, Raquel
dc.contributor.authorAutonell, Josefina
dc.contributor.authorSarda, Montserrat
dc.contributor.authorCrespo, Nàyade
dc.contributor.authorPique, Pilar
dc.contributor.authorPascual, Amparo
dc.contributor.authorMartí, Clara
dc.contributor.authorFibla, Montserrat
dc.contributor.authorGutiérrez Miguélez, Cristina
dc.contributor.authorLloveras Rubio, Betlem
dc.contributor.authorMoreno Crespi, Judit
dc.contributor.authorTorrent, Anna
dc.contributor.authorBaixeras, Núria
dc.contributor.authorAlejo, Maria
dc.contributor.authorBosch José, Francesc Xavier, 1947-
dc.contributor.authorSanjosé Llongueras, Silvia de
dc.date.accessioned2018-09-10T07:16:11Z
dc.date.available2018-09-10T07:16:11Z
dc.date.issued2014-08-08
dc.date.updated2018-07-24T12:38:26Z
dc.description.abstractBackground: Poor attendance to cervical cancer (CC) screening is a major risk factor for CC. Efforts to capture underscreened women are considerable and once women agree to participate, the provision of longitudinal validity of the screening test is of paramount relevance. We evaluate the addition of high risk HPV test (HPV) to cervical cytology as a primary screening test among underscreened women in the longitudinal prediction of intraepithelial lesions grade 2 or worse (CIN2+). Methods: Women were included in the study if they were older than 39 years and with no evidence of cervical cytology in the previous five years within the Public Primary Health Care System in Catalonia (Spain). 1,832 underscreened women from eight public primary health areas were identified during 2007-2008 and followed-up for over three years to estimate longitudinal detection of CIN2+. Accuracy of each screening test and the combination of both to detect CIN2+ was estimated. The risk of developing CIN2+ lesions according to histology data by cytology and HPV test results at baseline was estimated using the Kaplan-Meier method. Results: At baseline, 6.7% of participants were HPV positive, 2.2% had an abnormal cytology and 1.3% had both tests positive. At the end of follow-up, 18 out of 767 (2.3%) underscreened women had a CIN2+, two of which were invasive CC. The three-year longitudinal sensitivity and specificity estimates to detect CIN2+ were 90.5% and 93.0% for HPV test and 38.2% and 97.8% for cytology. The negative predictive value was >99.0% for each test. No additional gains in validity parameters of HPV test were observed when adding cytology as co-test. The referral to colposcopy was higher for HPV but generated 53% higher detection of CIN2+ compared to cytology. Conclusions: Underscreened women had high burden of cervical disease. Primary HPV screening followed by cytology triage could be the optimal strategy to identify CIN2+ leading to longer and safe screen intervals.
dc.format.extent8 p.
dc.format.mimetypeapplication/pdf
dc.identifier.pmid25102758
dc.identifier.urihttps://hdl.handle.net/2445/124383
dc.language.isoeng
dc.publisherBioMed Central
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1186/1471-2407-14-574
dc.relation.ispartofBMC Cancer, 2014, vol. 14, num. 574
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/FP7/242061/EU//PREHDICT
dc.relation.urihttps://doi.org/10.1186/1471-2407-14-574
dc.rightscc by (c) Ibáñez et al., 2014
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationPapil·lomavirus
dc.subject.classificationCàncer de coll uterí
dc.subject.otherPapillomaviruses
dc.subject.otherCervix cancer
dc.titleProtecting the underscreened women in developed countries: the value of HPV test
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
IbanezR.pdf
Mida:
505.46 KB
Format:
Adobe Portable Document Format